Abstract
Recombinase-aided amplification (RAA) combined with lateral flow strips offers a practical path for rapid molecular POCT. Compared with conventional PCR workflows, RAA can operate under isothermal conditions and can be paired with visual strip readout. For distributors and assay developers, the key is not only amplification speed but also complete workflow compatibility, stable reagents, and reliable OEM support from a capable POCT manufacturer.
Introduction
Point-of-care molecular testing is expanding beyond centralized laboratories. Clinics, field screening programs, veterinary testing, and decentralized infectious disease surveillance all need methods that are fast, simple, and less dependent on large instruments. RAA lateral flow detection is one of the formats gaining attention because it links molecular specificity with easy visual interpretation.
Workflow Overview
A typical RAA-LFD workflow contains sample preparation, isothermal amplification, lateral flow detection, and result interpretation. The amplified product is designed with labels that can be captured on a strip. When the target is present, a visible test line appears within minutes.
Key Benefits
- Lower equipment requirement: RAA can run at moderate temperature, reducing dependence on full thermal cyclers.
- Fast turnaround: Amplification and strip readout can be completed in a short workflow suitable for near-patient use.
- Visual interpretation: A lateral flow strip can provide clear positive/negative results without complex optical systems.
- OEM potential: The format can be adapted for pathogen detection, food safety, animal health, and environmental monitoring.
Supplier Criteria
When selecting an RAA lateral flow partner, distributors should evaluate both the amplification reagent and the strip. A weak strip can undermine a strong amplification reaction, while unstable amplification chemistry can create inconsistent line intensity. Supplier evaluation should include stability, background control, limit-of-detection verification, packaging, and documentation.
Materials Required
- RAA amplification reagent or lyophilized format
- Dual-labeled primers or probes
- Lateral flow strip compatible with the label system
- Running buffer and sample preparation reagent
- Positive and negative controls
Step-by-Step Protocol
- Prepare sample nucleic acid using a compatible extraction or release method.
- Set up the RAA reaction with labeled primers or probes.
- Incubate under the recommended isothermal condition.
- Apply the amplified product to the lateral flow strip with running buffer.
- Read the control line and test line within the specified time window.
Common Troubleshooting Questions
Q: Why does the negative control show a faint test line?
This may indicate primer-dimer formation, carryover contamination, excessive reaction time, or strip background. Workflow separation and primer optimization are important.
Q: Can RAA-LFD replace PCR?
It depends on the application. PCR remains strong for laboratory confirmation, while RAA-LFD is attractive for rapid screening and decentralized testing.
Q: What should be validated before commercialization?
Analytical sensitivity, specificity, cross-reactivity, stability, operator variability, and sample matrix effects should all be evaluated.
Conclusion & OEM/ODM CTA
TiosBio provides RAA-compatible lateral flow detection solutions and OEM/ODM support for rapid molecular diagnostic development. Founded in 1987, TiosBio helps distributors build practical POCT portfolios. Contact medtiger@foxmail.com for specifications and cooperation options.